Plain-English translation of NCT07478796 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing three antidepressant medications—, , and sertraline—to figure out which doses work best for young people and adults with moderate to severe depression. Researchers will take blood samples to measure how much medication is in your system and track how well the treatment is working for you. The goal is to create better dosing guidelines so doctors can prescribe the right amount from the start, rather than guessing.
Depression in young people can cause serious problems with school, friendships, and overall health, and can even increase suicide risk. Right now, doctors don't have clear, science-based guidelines for dosing these common medications in younger patients, so they often use outdated approaches or have to adjust doses through trial and error.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take one of the three medications once daily, starting at a conservative dose. Your doctor will check how you're doing after 3 weeks, and may increase your dose if you're not showing improvement. Throughout the study, you'll have blood tests to measure the medication level in your body, and researchers will use that information to help guide your treatment. The study uses this personalized monitoring approach to figure out what dose works best for you and to gather data that will help doctors treat other young people with depression more effectively.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
Poland